<?xml version="1.0" encoding="utf-8" ?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN"
                  "JATS-publishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.2" article-type="other">
<front>
<journal-meta>
<journal-id></journal-id>
<journal-title-group>
<journal-title>NeuroLibre Reproducible Preprints</journal-title>
<abbrev-journal-title>NeuroLibre</abbrev-journal-title>
</journal-title-group>
<issn publication-format="electronic">0000-0000</issn>
<publisher>
<publisher-name>NeuroLibre</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">39</article-id>
<article-id pub-id-type="doi">10.55458/neurolibre.00039</article-id>
<title-group>
<article-title>Parkinson’s disease in the spinal cord: an exploratory
study to establish T2*w, MTR and diffusion-weighted imaging metric
values</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-7572-8504</contrib-id>
<name>
<surname>St-Onge</surname>
<given-names>Samuelle</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
<xref ref-type="aff" rid="aff-2"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Coustaury</surname>
<given-names>Camille</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Landelle</surname>
<given-names>Caroline</given-names>
</name>
<xref ref-type="aff" rid="aff-3"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1090-7138</contrib-id>
<name>
<surname>Dahlberg</surname>
<given-names>Linda Solstrand</given-names>
</name>
<xref ref-type="aff" rid="aff-3"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6608-5818</contrib-id>
<name>
<surname>Lungu</surname>
<given-names>Ovidiu</given-names>
</name>
<xref ref-type="aff" rid="aff-3"/>
<xref ref-type="aff" rid="aff-4"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Doyon</surname>
<given-names>Julien</given-names>
</name>
<xref ref-type="aff" rid="aff-3"/>
</contrib>
<contrib contrib-type="author">
<contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1378-2756</contrib-id>
<name>
<surname>Leener</surname>
<given-names>Benjamin De</given-names>
</name>
<xref ref-type="aff" rid="aff-1"/>
<xref ref-type="aff" rid="aff-2"/>
<xref ref-type="aff" rid="aff-5"/>
</contrib>
<aff id="aff-1">
<institution-wrap>
<institution>NeuroPoly Lab, Institute of Biomedical Engineering,
Polytechnique Montréal, Montreal, QC, Canada.</institution>
</institution-wrap>
</aff>
<aff id="aff-2">
<institution-wrap>
<institution>CHU Sainte-Justine Research Centre, Montreal, QC,
Canada.</institution>
</institution-wrap>
</aff>
<aff id="aff-3">
<institution-wrap>
<institution>McConnell Brain Imaging Centre, Department of Neurology and
Neurosurgery, Montreal Neurological Institute, McGill University,
Montreal, QC, Canada.</institution>
</institution-wrap>
</aff>
<aff id="aff-4">
<institution-wrap>
<institution>Département de psychiatrie et addictologie, Université de
Montréal, Montreal, QC, Canada.</institution>
</institution-wrap>
</aff>
<aff id="aff-5">
<institution-wrap>
<institution>Computer Engineering and Software Engineering,
Polytechnique Montréal, Montreal, QC, Canada.</institution>
</institution-wrap>
</aff>
</contrib-group>
<pub-date date-type="pub" publication-format="electronic" iso-8601-date="2025-05-21">
<day>21</day>
<month>5</month>
<year>2025</year>
</pub-date>
<volume>5</volume>
<issue>54</issue>
<fpage>39</fpage>
<permissions>
<copyright-statement>Authors of papers retain copyright and release the
work under a Creative Commons Attribution 4.0 International License (CC
BY 4.0)</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>The article authors</copyright-holder>
<license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by/4.0/">
<license-p>Authors of papers retain copyright and release the work under
a Creative Commons Attribution 4.0 International License (CC BY
4.0)</license-p>
</license>
</permissions>
<kwd-group kwd-group-type="author">
<kwd>Preprint</kwd>
<kwd>Spinal Cord</kwd>
<kwd>Parkinson's disease</kwd>
<kwd>MRI</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="abstract">
  <title>Abstract</title>
  <p>Parkinson’s disease (PD) is primarily defined by brain pathology,
  including dopamine neuron degeneration and α-synuclein aggregation.
  Emerging evidence suggests that the spinal cord is also affected, with
  ex-vivo studies reporting abnormal α-synuclein protein aggregation
  within the spinal cord of PD patients. While advanced imaging
  techniques, such as diffusion tensor imaging (DTI), neurite
  orientation dispersion and density imaging (NODDI),
  T2<italic>-weighted (T2</italic>w) imaging, and the magnetization
  transfer ratio (MTR) have demonstrated potential for detecting
  PD-related changes in the brain, their application to uncover spinal
  cord alterations remains unexplored. This study is the first to
  investigate MRI-derived microstructural metrics in the spinal cord of
  PD patients, comparing them to healthy controls. Although this study
  found limited microstructural or structural differences in the spinal
  cord between PD patients and healthy controls, these findings are
  consistent with recent results from PD mouse models and complement an
  earlier functional MRI study using the same cohort, where significant
  findings were observed. Our lack of significant structural findings
  may suggest that functional spinal cord changes are more sensitive
  markers of Parkinson’s disease progression — particularly in relation
  to clinical measures such as the Unified Parkinson’s Disease Rating
  Scale (UPDRS). These results highlight the need for further research
  to better understand how PD-related alterations in the spinal cord
  compare to normal aging processes and relate to functional
  changes.</p>
</sec>
<sec id="introduction">
  <title>Introduction</title>
  <p>Parkinson’s disease (PD) is a neurodegenerative disease that is
  defined by both the degeneration of dopamine-producing neurons inside
  the substantia nigra
  (<xref alt="Nyatega et al., 2022" rid="ref-nyatega_gray_2022" ref-type="bibr">Nyatega
  et al., 2022</xref>) and the abnormal accumulation of α-synuclein
  inside neurons, forming abnormal protein aggregates commonly referred
  to as Lewy bodies
  (<xref alt="Bianco et al., 2002" rid="ref-bianco_-synucleinopathy_2002" ref-type="bibr">Bianco
  et al., 2002</xref>;
  <xref alt="Muller et al., 2005" rid="ref-muller_staging_2005" ref-type="bibr">Muller
  et al., 2005</xref>). While PD has traditionally been linked to brain
  pathology, markers of the disease have been identified in the spinal
  cord, notably the presence of abnormal aggregation of α-synuclein
  proteins inside spinal cord axons
  (<xref alt="Nardone et al., 2020" rid="ref-nardone_spinal_2020" ref-type="bibr">Nardone
  et al., 2020</xref>).</p>
  <p>Indeed, post-mortem studies have reported a higher number of
  α-synuclein aggregates in the spinal cord of PD patients compared to
  their healthy counterparts
  (<xref alt="Braak et al., 2007" rid="ref-braak_parkinsons_2007" ref-type="bibr">Braak
  et al., 2007</xref>;
  <xref alt="Kelly Del Tredici &amp; Braak, 2012" rid="ref-del_tredici_spinal_2012" ref-type="bibr">Kelly
  Del Tredici &amp; Braak, 2012</xref>). While cases of α-synuclein
  aggregates found exclusively in the spinal cord are rare,
  α-synucleinopathy is commonly observed in the spinal cord when it is
  also present in the brain. This pattern suggests that, in such cases,
  PD may affect the midbrain before the spinal cord
  (<xref alt="Kelly Del Tredici &amp; Braak, 2012" rid="ref-del_tredici_spinal_2012" ref-type="bibr">Kelly
  Del Tredici &amp; Braak, 2012</xref>). There is also extensive
  evidence indicating that PD may originate in the enteric nervous
  system (ENS) before progressing to the midbrain
  (<xref alt="Kelly Del Tredici &amp; Braak, 2012" rid="ref-del_tredici_spinal_2012" ref-type="bibr">Kelly
  Del Tredici &amp; Braak, 2012</xref>;
  <xref alt="K. Del Tredici &amp; Braak, 2016" rid="ref-del_tredici_review_2016" ref-type="bibr">K.
  Del Tredici &amp; Braak, 2016</xref>), supporting the distinction
  between body-first and brain-first subtypes of PD
  (<xref alt="Horsager et al., 2020" rid="ref-horsager_brain-first_2020" ref-type="bibr">Horsager
  et al., 2020</xref>;
  <xref alt="Leclair-Visonneau et al., 2020" rid="ref-leclair-visonneau_gut_2020" ref-type="bibr">Leclair-Visonneau
  et al., 2020</xref>). Post-mortem studies further suggest that
  brain-first PD may begin in the olfactory system or the amygdala
  (<xref alt="Horsager et al., 2020" rid="ref-horsager_brain-first_2020" ref-type="bibr">Horsager
  et al., 2020</xref>). Nonetheless, the origin of PD within the body
  remains under debate, along with the mechanisms through which the
  disease spreads to the spinal cord.</p>
  <p>The work of
  (<xref alt="Bloch et al., 2006" rid="ref-bloch_-synuclein_2006" ref-type="bibr">Bloch
  et al., 2006</xref>) has shown a higher concentration of α-synuclein
  in the lower brainstem than in the spinal cord, which is consistent
  with the findings of
  (<xref alt="Kelly Del Tredici &amp; Braak, 2012" rid="ref-del_tredici_spinal_2012" ref-type="bibr">Kelly
  Del Tredici &amp; Braak, 2012</xref>). Furthermore,
  (<xref alt="Kelly Del Tredici &amp; Braak, 2012" rid="ref-del_tredici_spinal_2012" ref-type="bibr">Kelly
  Del Tredici &amp; Braak, 2012</xref>) identified globules filled with
  α-synuclein in individuals with advanced PD, as opposed to small
  varicosities in earlier stages, consistent with findings from
  (<xref alt="Sekigawa et al., 2015" rid="ref-sekigawa_role_2015" ref-type="bibr">Sekigawa
  et al., 2015</xref>), who observed axonal swelling associated to
  α-synuclein in the spinal cord of transgenic mice. Recently,
  (<xref alt="Combes et al., 2024" rid="ref-combes_spiral_2024" ref-type="bibr">Combes
  et al., 2024</xref>) have studied structural MRI in the spinal cord of
  transgenic PD mice. Their results revealed no structural changes in
  the spinal cord of the PD mouse compared with their non-transgenic
  counterparts. Functional aspects of PD in the human spinal cord have
  been explored in-vivo by
  (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
  et al., 2023</xref>), using functional magnetic resonance imaging
  (fMRI), where a decrease of functional connectivity in conjunction
  with disease progression has been observed in the cervical spinal
  cord. Nevertheless, <italic>in-vivo</italic> spinal cord studies for
  PD remain limited, and the structural aspects of PD on the human
  spinal cord remain unexplored, hence the relevance of investigating
  MRI-derived metrics on the human spinal cord,
  <italic>in-vivo</italic>.</p>
  <p>Diffusion-weighted imaging (DWI) is a promising modality to
  quantify spinal cord microstructure, as it provides information
  regarding the diffusion of water molecules that can indicate tissue
  abnormalities and damage. The diffusion tensor imaging (DTI) model is
  amongst the most widely used diffusion MRI models, allowing to measure
  fractional anisotropy (FA), mean diffusivity (MD), radial diffusivity
  (RD) and axial diffusivity (AD)
  (<xref alt="O’Donnell &amp; Westin, 2011" rid="ref-odonnell_introduction_2011" ref-type="bibr">O’Donnell
  &amp; Westin, 2011</xref>). Although a few studies have investigated
  DTI to quantify gray matter integrity such as in healthy aging
  (<xref alt="Pfefferbaum et al., 2010" rid="ref-pfefferbaum_diffusion_2010" ref-type="bibr">Pfefferbaum
  et al., 2010</xref>), DTI is predominantly used to study the white
  matter, given its strong anisotropy
  (<xref alt="Assaf &amp; Pasternak, 2008" rid="ref-assaf_diffusion_2008" ref-type="bibr">Assaf
  &amp; Pasternak, 2008</xref>). Recent work has demonstrated the
  usefulness of DTI to unveil microstructural tissue damage in PD
  patients for several regions of the brain, such as the substantia
  nigra and corpus callosum
  (<xref alt="Atkinson-Clement et al., 2017" rid="ref-atkinson-clement_diffusion_2017" ref-type="bibr">Atkinson-Clement
  et al., 2017</xref>;
  <xref alt="Kotian et al., 2020" rid="ref-kotian_diffusion_2020" ref-type="bibr">Kotian
  et al., 2020</xref>). Notably, a decrease in FA has been reported with
  PD progression in the brain
  (<xref alt="Kotian et al., 2020" rid="ref-kotian_diffusion_2020" ref-type="bibr">Kotian
  et al., 2020</xref>). Yet, although DTI metrics have demonstrated
  potential for identifying PD-related microstructural changes at the
  brain level, to our knowledge, these metrics have not been studied in
  the spinal cord of PD patients.</p>
  <p>Another DWI model that shows promise is the Neurite Orientation
  Dispersion and Density Index (NODDI)
  (<xref alt="Zhang et al., 2012" rid="ref-zhang_noddi_2012" ref-type="bibr">Zhang
  et al., 2012</xref>), which allows tissue voxels to be
  compartmentalized into intracellular, extracellular and cerebrospinal
  fluid compartments. NODDI metrics include the orientation dispersion
  index (ODI), the isotropic volume fraction (FISO) and neurite density
  (FICVF). Previous brain-focused studies have reported reduced values
  for FICVF and ODI in the substantia nigra pars compacta among
  individuals with PD
  (<xref alt="Kamagata, Hatano, &amp; Aoki, 2016" rid="ref-kamagata_what_2016" ref-type="bibr">Kamagata,
  Hatano, &amp; Aoki, 2016</xref>;
  <xref alt="Kamagata, Hatano, Okuzumi, et al., 2016" rid="ref-kamagata_neurite_2016" ref-type="bibr">Kamagata,
  Hatano, Okuzumi, et al., 2016</xref>); a phenomenon suspected to be
  linked to the loss of dopaminergic neurons associated with PD in the
  brain
  (<xref alt="Kamagata, Hatano, &amp; Aoki, 2016" rid="ref-kamagata_what_2016" ref-type="bibr">Kamagata,
  Hatano, &amp; Aoki, 2016</xref>). Also in the brain,
  (<xref alt="Mitchell et al., 2019" rid="ref-mitchell_neurite_2019" ref-type="bibr">Mitchell
  et al., 2019</xref>) found that ODI increased in white matter while
  decreasing in gray matter, suggesting possible axonal degeneration or
  disorganization in white matter, and dendritic thinning in gray
  matter. However, to our knowledge, no <italic>in vivo</italic> studies
  have demonstrated neuronal loss related to PD in the spinal cord.</p>
  <p>Others have explored T2*-weighted (T2*w), or its reciprocal R2*
  (1/T2*), as a promising method for identifying PD-related changes in
  the brain. In their study,
  (<xref alt="Schwarz et al., 2018" rid="ref-schwarz_parkinsons_2018" ref-type="bibr">Schwarz
  et al., 2018</xref>) noticed a decrease in T2*w signal inside the
  substantia nigra and nigrosomes in subjects with PD compared to
  healthy individuals. Since T2*w is sensitive to changes in
  susceptibility, this decrease has been attributed to iron
  accumulation, which is well documented in the brain of PD patients
  (<xref alt="Schwarz et al., 2018" rid="ref-schwarz_parkinsons_2018" ref-type="bibr">Schwarz
  et al., 2018</xref>;
  <xref alt="Nicola Tambasco et al., 2019" rid="ref-tambasco_t2-weighted_2019" ref-type="bibr">Nicola
  Tambasco et al., 2019</xref>;
  <xref alt="Zeng et al., 2024" rid="ref-zeng_iron_2024" ref-type="bibr">Zeng
  et al., 2024</xref>). Studies suggest that iron deposition is
  responsible for triggering the activation of immune cells in the
  brain, which in turn release substances that cause inflammation and
  cause oxidative stress. This process may aggravate the loss of
  dopaminergic neurons and contribute to disease progression in PD
  patients
  (<xref alt="Zeng et al., 2024" rid="ref-zeng_iron_2024" ref-type="bibr">Zeng
  et al., 2024</xref>). Iron accumulation related to PD in the spinal
  cord has not been reported to date. However, given that the
  involvement of the spinal cord in PD is still not fully understood,
  exploring T2*w in the spinal cord of PD patients may reveal subtle
  changes in tissue susceptibility that were not identified in previous
  post-mortem studies. Similarly, the magnetization transfer ratio (MTR)
  has demonstrated relevance in the context of PD in the brain, where
  studies have noted a decrease in MTR in several brain regions such as
  the substantia nigra in early PD stages, which is thought to also be
  linked to iron deposition in the brain
  (<xref alt="Anik et al., 2007" rid="ref-anik_magnetization_2007" ref-type="bibr">Anik
  et al., 2007</xref>;
  <xref alt="N. Tambasco et al., 2011" rid="ref-tambasco_magnetization_2011" ref-type="bibr">N.
  Tambasco et al., 2011</xref>;
  <xref alt="Nicola Tambasco et al., 2019" rid="ref-tambasco_t2-weighted_2019" ref-type="bibr">Nicola
  Tambasco et al., 2019</xref>). However, despite the interest in
  studying T2*w and MTR metrics in the PD brain, their investigation for
  PD in the spinal cord remains unexplored.</p>
  <p>The present study thus seeks to address all the above-mentioned
  knowledge gaps by assessing the potential of quantitative MRI to
  detect microstructural changes in the spinal cord related to
  Parkinson’s disease. We aim to establish relationships between PD
  progression and T2*w, MTR, DTI and NODDI values in the cervical spinal
  cord. Disease progression was assessed using the motor component of
  the Unified Parkinson’s Disease Rating Scale (UPDRS)
  (<xref alt="Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease, 2003" rid="ref-movement_disorder_society_task_force_on_rating_scales_for_parkinsons_disease_unified_2003" ref-type="bibr">Movement
  Disorder Society Task Force on Rating Scales for Parkinson’s Disease,
  2003</xref>) to correlate these metrics with motor symptom severity.
  Additionally, PD stage was explored by categorizing participants into
  early, mid and advanced groups based on their UPDRSIII motor scores.
  The study also seeks to evaluate whether DTI, NODDI, T2*w and MTR
  metrics can be used to differentiate PD patients from their healthy
  counterparts, which could lead to identifying potential biomarkers for
  PD in the spinal cord.</p>
</sec>
<sec id="methods">
  <title>Methods</title>
  <sec id="data-acquisition">
    <title>Data acquisition</title>
    <p>The study involved the same participants as in
    (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
    et al., 2023</xref>), who have been scanned at the Montreal
    Neurological Institute-Hospital using a 3 Tesla MRI scanner
    (Magnetom Prisma, Siemens, Erlangen, Germany). All participants gave
    their written consent in accordance with the Helsinki Declaration,
    and the experiment was approved by the local ethics committee (MUCH
    REB 2019-4626). The acquisition protocol included a T1w, T2*w,
    magnetization transfer (MT) and a multi-shell diffusion MRI
    sequence. The detailed acquisition parameters for T2*w, MTR and DWI
    are presented in <xref alt="Figure 1" rid="fig1">Figure 1</xref>.
    <xref alt="Figure 2" rid="fig2">Figure 2</xref> shows examples of
    raw data acquisitions for a single subject. Because of the limited
    field-of-view of the acquisitions, only the cervical spinal cord
    from spinal levels C2 to C5 was considered for this study.</p>
    <p>Participants (N=106; 65 M, 41 F) included both patients with PD
    (N=68; 47 M, 21 F) and matched healthy control subjects (HC) (N=38;
    20 F, 18 M). Individuals with PD underwent clinical interviews and
    neurological examinations, including an assessment of disease
    severity with the UPDRS. Using Part III of the UPDRS, which
    corresponds to the assessment of motor symptoms, participants with
    PD were further categorized into three group stages: early PD
    (UPDRSIII 0-20), mid PD (UPDRSIII 20-30), advanced PD (UPDRSIII
    30-60). The participants’ ages ranged from 38 to 83 years old. The
    mean ages and standard deviations for each group were as follows:
    overall (N = 106): mean = 64, SD = 10; healthy controls (N=38) :
    mean= 62, SD = 11; early PD (N=23) : mean = 61, SD = 10; mid PD
    (N=22): mean = 64, SD = 7; advanced PD (N=23): mean = 68, SD = 10.
    <xref alt="Figure 1" rid="fig1">Figure 1</xref> shows the number of
    participants per category, for each sequence. The age, sex and
    UPDRSIII score distribution of the subjects are also presented in
    <xref alt="Figure 1" rid="fig1">Figure 1</xref>.</p>
    <p>:::{figure} #fig1cell :label: fig1</p>
    <list list-type="alpha-upper">
      <list-item>
        <label>(A)</label>
        <p>Acquisition parameters for T2*w, MTR and DWI; (B) Number of
        participants per category (controls, early PD, mid PD and
        advanced PD) for each sequence according to their UPDRSIII score
        (C) Age and UPDRSIII distributions. :::</p>
      </list-item>
    </list>
    <p>:::{figure} #fig2cell :label: fig2</p>
    <p>Representative raw data of T2*w, MT0/MT1, and DWI from a single
    subject. :::</p>
  </sec>
  <sec id="data-pre-processing-and-metric-extraction">
    <title>Data pre-processing and metric extraction</title>
    <p>FA, MD, RD and AD metrics were computed from the DWI images using
    DTI from DIPY via the
    <ext-link ext-link-type="uri" xlink:href="https://spinalcordtoolbox.com/stable/index.html">Spinal
    Cord Toolbox (SCT)</ext-link>
    (<xref alt="De Leener et al., 2017" rid="ref-de_leener_sct_2017" ref-type="bibr">De
    Leener et al., 2017</xref>). ODI, FISO and FICVF metrics were
    computed using the
    <ext-link ext-link-type="uri" xlink:href="http://mig.cs.ucl.ac.uk/index.php?n=Tutorial.NODDImatlab">NODDI
    Matlab Toolbox</ext-link>
    (<xref alt="UCL Microstructure Imaging Group, 2021" rid="ref-ucl_microstructure_imaging_group_noddi_2021" ref-type="bibr">UCL
    Microstructure Imaging Group, 2021</xref>). The motion correction
    algorithm from SCT was attempted on the DWI images but did not
    improve image quality and occasionally introduced noise; therefore,
    uncorrected data were used in subsequent analyses. Using SCT,
    magnetization transfer (MT) images with and without the MT pulse
    were co-registered, and magnetization transfer ratio (MTR) maps were
    computed from the co-registered data. The individual MTR, T2*w and
    DWI images underwent initial preprocessing with SCT, which first
    included spinal cord segmentation using the sct_propseg algorithm
    and manual corrections when necessary. Because of the thick slices
    of T2*w (2 mm), MTR and DWI (5 mm) acquisitions, it was difficult to
    label the vertebrae on these images directly. For this reason,
    vertebral labeling was performed on T1w acquisitions (slice
    thickness = 1.3 mm) and were coregistered to the
    <ext-link ext-link-type="uri" xlink:href="https://spinalcordtoolbox.com/stable/overview/concepts/pam50.html">PAM50
    template</ext-link>
    (<xref alt="De Leener et al., 2018" rid="ref-de_leener_pam50_2018" ref-type="bibr">De
    Leener et al., 2018</xref>). Then, the generated warping fields were
    used to initialize the coregistration of T2*w, MTR, DTI and NODDI
    images to the PAM50 template. Thus we generated average group-level
    metric maps (i.e., average pixel wise intensity) for both HC and PD
    subjects, at spinal levels C2 to C5 in the PAM50 space.</p>
    <p>Using the atlas from the co-registered PAM50 template, we
    extracted DTI metrics from the white matter and its subregions
    (dorsal columns, ventral funiculi, and lateral funiculi) to quantify
    axonal damage, which may be linked to the presence of α-synuclein
    aggregates in white matter axons, leading to reduced diffusion
    anisotropy. Similarly, NODDI metrics were extracted from the white
    matter and its subregions for their sensitivity to axonal integrity
    and changes in diffusion orientation. Additionally, NODDI metrics
    were analyzed in the gray matter to detect potential alterations in
    dendrite orientation and integrity. MTR values were extracted from
    the white matter and its subregions due to their sensitivity to
    demyelination, often linked to axonal loss. Finally, the white
    matter to gray matter ratio (WM/GM) ratio was calculated from T2*w
    images using white and gray matter values extracted using the PAM50
    atlas. The ratio was chosen because gray matter naturally contains
    higher iron levels than white matter, and T2*w is particularly
    sensitive to iron content.</p>
    <p>Importantly, all metrics were extracted using the spinal levels
    (<xref alt="Frostell et al., 2016" rid="ref-frostell_review_2016" ref-type="bibr">Frostell
    et al., 2016</xref>) instead of the vertebral levels, to offer a
    representation that reflects more accurately the functional
    organization of the spinal cord into different rootlets, thereby
    enabling more robust comparisons with the findings of
    (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
    et al., 2023</xref>) in functional MRI. The cross-sectional area of
    the spinal cord was also computed on all individual T2*w images via
    <italic>sct_process_segmentation</italic> from SCT.</p>
  </sec>
  <sec id="effect-of-groups-and-updrsiii-score-on-mri-metrics">
    <title>Effect of groups and UPDRSIII score on MRI metrics</title>
    <p>We investigated the relationships between PD and MRI-derived
    metrics (DTI, NODDI, T2*w ratio, and MTR) in the cervical spinal
    cord by examining how the metrics varied across different groups
    (controls, early PD, mid PD, and advanced PD). To this end, we
    performed an analysis of variance (ANOVA) on the mean metric value
    extracted across spinal levels C2–C5. Age was included as a
    covariate to control for its potential confounding effects. Post-hoc
    t-tests were performed on metrics that showed significant results (p
    &lt; 0.05) to further explore group differences.</p>
    <p>To explore the relationship between disease progression and
    microstructural changes detectable through our metrics, we employed
    an ordinary least-squares (OLS) regression model to assess the
    correlations between DTI, NODDI, T2*w, and MTR metrics with UPDRSIII
    scores, while controlling for age as a potential confounder. For
    each metric, the OLS analysis was performed for spinal levels C2 to
    C5 separately. DTI, NODDI and MTR metrics were studied in the white
    matter and its subregions (dorsal columns, ventral funiculi, lateral
    funiculi) to identify potential changes which may be attributed to
    the accumulation of α-synuclein inside white matter axons. Due to
    its ability to identify changes in gray matter dendrites, NODDI was
    also calculated in the gray matter, to investigate whether
    differences in these metrics could be identified with an increasing
    UPDRSIII score. Finally, the WM/GM was studied using T2*w images. To
    control for the risk of type I errors due to multiple comparisons,
    the p-values were adjusted using the Benjamini-Hochberg method, also
    known as the false-discovery rate (FDR) correction. Cross-sectional
    area (CSA) was also examined using the above-mentioned ANOVA and OLS
    models to detect potential structural changes in the cervical spinal
    cord associated with PD.</p>
  </sec>
</sec>
<sec id="results">
  <title>Results</title>
  <sec id="average-metric-maps">
    <title>Average metric maps</title>
    <p><xref alt="Fig. %sf" rid="fig3">Fig. %sf</xref> shows the average
    metric maps for DTI, NODDI and MTR, obtained by registering the
    metrics to the PAM50 template and computing the pixel-by-pixel
    average intensity for each subject category (HC, early PD, mid PD
    and advanced PD).</p>
    <p>:::{figure} #fig3cell :label: fig3</p>
    <p>Average spinal cord maps of DTI, NODDI and MTR metrics for C2,
    C3, C4, and C5 spinal levels in healthy control participants (HC),
    early PD, mid PD, advanced PD and all PD participants combined.
    :::</p>
    <p>The average metric maps in <xref alt="Figure 3" rid="fig3">Figure
    3</xref> revealed an increase in ODI and a decrease in FA within the
    white matter among PD participants compared to their healthy
    counterparts. Additionally, a decrease in global intensity is
    observed as we progress through the more caudal spinal levels, which
    is particularly apparent in MTR and FA maps.</p>
  </sec>
  <sec id="cross-sectional-area-csa-of-pd-subjects-versus-healthy-controls">
    <title>Cross-sectional area (CSA) of PD subjects versus healthy
    controls</title>
    <p><xref alt="Fig. %sf" rid="fig4">Fig. %sf</xref> presents the
    results of ANOVA comparing spinal cord cross-sectional area (CSA)
    across HC, early PD, mid PD, and advanced PD groups. The results
    revealed no significant differences in spinal cord cross-sectional
    area (CSA) between groups. Additionally, an OLS analysis revealed no
    significant correlation between the UPDRSIII score and the CSA
    (Table 1), but rather a significant correlation of age and CSA at C3
    and C4 spinal levels (p-Age = 0.002). These results suggest that the
    cervical spinal cord CSA is not affected by PD.</p>
    <p>:::{figure} #fig4cell :label: fig4</p>
    <p>Fig 4. ANOVA for the spinal cord cross-sectional area (CSA) for
    HC in comparison with PD subjects categorized by their UPDRSIII
    score (early PD, mid PD and advanced PD), for spinal levels C2 to C5
    combined. :::</p>
    <p>:::{figure} content/tables/table1.png</p>
    <p>Table 1. P-values for UPDRSIII and Age variables for the
    cross-sectional area (CSA) following ordinary least squares (OLS)
    analysis. The significance level was corrected for each metric, by
    dividing α=0.05 by the number of spinal levels studied. :::</p>
  </sec>
  <sec id="comparisons-across-groups-healthy-controls-early-pd-mid-pd-and-advanced-pd">
    <title>Comparisons across groups (healthy controls, early PD, mid PD
    and advanced PD)</title>
    <p><xref alt="Figure 5" rid="fig5">Figure 5</xref> presents the
    results of an ANOVA comparing DTI, NODDI, MTR, and T2*w metrics
    across the different groups (HC, early PD, mid PD, and advanced PD).
    In the white matter, our results showed a significant effect of
    group on FA and RD metrics, for the combined spinal levels C2 to C5
    (FA : p-Group = 0.0180; RD : p-Group = 0.0179). Post-hoc pairwise
    t-tests with false discovery rate (FDR) correction were then applied
    to FA and RD in WM to compare early PD, mid PD and advanced PD
    subjects with the HC group (Table 2), where results showed a
    significant difference between HC and the advanced PD group for FA
    in the WM (p=0.0402), and between HC and mid PD for RD in the WM
    (p=0.0281).</p>
    <p>:::{figure} #fig5cell :label: fig5</p>
    <p>Fig 5. ANOVA for NODDI, DTI, T2*w and MTR across groups (HC,
    early PD, mid PD, adv PD) in (A) the white matter, (B) the gray
    matter and (C) the white matter to gray matter ratio, for spinal
    levels C2 to C5 combined. Significant group differences are
    indicated with a red asterisk (*). :::</p>
    <p>:::{figure} content/tables/table2.png</p>
    <p>Table 2. FDR-corrected p-values following post-hoc pairwise
    t-tests between HC – early PD, HC – mid PD and HC – advanced PD. The
    significant p-values (&lt;0.05) are shown in red with an asterisk
    (*). :::</p>
  </sec>
  <sec id="correlation-analyses-with-updrsiii-scores">
    <title>Correlation analyses with UPDRSIII scores</title>
    <p>We employed an ordinary least-squares (OLS) regression model to
    explore the associations between DTI, NODDI, T2*w, and MTR metrics
    and UPDRSIII scores, with age included as a covariate to account for
    its potential confounding effects. Prior to conducting the OLS
    regression analysis, we assessed the potential collinearity between
    age and UPDRSIII scores. The Variance Inflation Factor (VIF) found
    was 1.1, which is well below the commonly-used threshold of 10,
    hence indicating minimal multicollinearity between age and UPDRSIII
    in our data. This suggests that age and UPDRSIII provide largely
    independent information, and including both in our model is unlikely
    to compromise its integrity. Furthermore, with a low Pearson
    coefficient of r=0.31, the relationship between UPDRSIII and age
    appears weak, suggesting that age alone is not a strong predictor of
    UPDRSIII in this cohort.</p>
    <p>Table 3 presents the p-values from the OLS model for the
    UPDRS-III and age variables, examining DTI, NODDI, and MTR metrics
    in relation to UPDRS-III score progression across each studied
    region. FDR correction was applied for each metric, taking into
    account all regions and vertebral levels shown in Table 3 (i.e., 16
    p-values for MTR and DTI metrics, 20 for NODDI, and 4 for T2*w).
    P-values in bold text marked with an asterisk (*) indicate
    statistical significance after applying FDR correction for multiple
    comparisons. Figures illustrating the regression plots for all
    metrics with respect to the UPDRSIII score, across each metric and
    spinal cord subregion, can be found in the supplementary
    material.</p>
    <p>As reported in Table 3, some trends were observed in specific
    regions, for individual spinal levels and for some of our metrics.
    Some p-values for the UPDRSIII score were below α = 0.05, but none
    remained significant after FDR correction. For instance, an increase
    in ODI, FICVF, and FISO was observed in relation to UPDRSIII across
    all spinal cord subregions, along with a decrease in FA, which was
    prominent at the C4 and C5 levels. The OLS regression model revealed
    an effect of the UPDRSIII on FA for the entire white matter at
    spinal levels C3 (p-UPDRSIII = 0.021) and C5 (p-UPDRSIII = 0.029),
    as well as in some sub-regions of the white matter. Effects of the
    UPDRSIII score were also observed on other metrics and regions such
    as RD at spinal level C2 (p-UPDRSIII = 0.043), FISO in the ventral
    funiculi at spinal level C2 (p-UPDRSIII = 0.013) and FICVF in the
    dorsal columns at spinal level C5 (p-UPDRSIII = 0.027). In the gray
    matter, the UPDRSIII revealed an effect on the FICVF at C5. Our
    findings also suggest an increase in the WM/GM ratio in T2*,
    particularly at the C4 spinal level. However, when correcting for
    multiple comparisons, no results were found significant for the
    UPDRSIII on any of the studied metrics and regions. Notably, the OLS
    model revealed a significant effect of age on MTR in the white
    matter (p-Age = 0.020) and in the dorsal columns (p-Age = 0.020) at
    spinal level C5, even when accounting for multiple comparisons. Age
    also demonstrated a significant correlation with the WM/GM ratio in
    T2*w for all spinal level regions (p-Age = 0.007 at C2; p-Age =
    0.049 at C3; p-Age = 0.022 at C4; p-Age = 0.022 at C5) after FDR
    correction.</p>
    <p>:::{figure} content/tables/table3.png</p>
    <p>Table 3. FDR-corrected p-values for UPDRSIII and age predictors
    for the OLS regression model (metric = UPDRSIII + Age) :::</p>
    <p>Regression plots of DTI, NODDI, MTR and T2*w metrics with respect
    to age for PD subjects and HC are provided in the supplementary
    material, across all spinal cord subregions and spinal levels. These
    figures show that the progression of values with age follows a very
    similar trend in both HC and PD subjects across all metrics and
    regions. This makes it challenging to differentiate between HC and
    PD subjects based solely on age-related changes. However, the
    observed trends, such as an increase in ODI and a decrease in FA,
    align with findings from previous studies investigating age-related
    changes in these metrics in healthy individuals
    (<xref alt="Agosta et al., 2007" rid="ref-agosta_evidence_2007" ref-type="bibr">Agosta
    et al., 2007</xref>;
    <xref alt="Vedantam et al., 2014" rid="ref-vedantam_diffusion_2014" ref-type="bibr">Vedantam
    et al., 2014</xref>;
    <xref alt="Wang et al., 2014" rid="ref-wang_age-related_2014" ref-type="bibr">Wang
    et al., 2014</xref>).</p>
  </sec>
</sec>
<sec id="discussion">
  <title>Discussion</title>
  <p>Based upon our ANOVA analysis, significant differences between HC
  and some PD groups were identified, notably between HC and the
  advanced PD group for FA in the WM, as well as between HC and the mid
  PD group in WM for RD. Our results also suggest an increase in ODI,
  FISO and FICVF as well as a decrease in FA with an increasing UPDRSIII
  score, which may be attributed to the accumulation of α-synuclein,
  which has been reported to cause axonal swelling
  (<xref alt="Sekigawa et al., 2015" rid="ref-sekigawa_role_2015" ref-type="bibr">Sekigawa
  et al., 2015</xref>), leading to greater neurite orientation
  dispersion and reduced diffusion anisotropy. However, since the trends
  observed in relation to the UPDRSIII score were not significant for
  any of the metrics after correcting for multiple comparisons,
  conclusive interpretations cannot be made based on the current
  study.</p>
  <p>Some studies have also investigated the presence of α-synuclein in
  the spinal cord of individuals without an antemortem diagnosis of PD
  and without any PD-related symptoms prior to death
  (<xref alt="Bloch et al., 2006" rid="ref-bloch_-synuclein_2006" ref-type="bibr">Bloch
  et al., 2006</xref>;
  <xref alt="Buchman et al., 2017" rid="ref-buchman_spinal_2017" ref-type="bibr">Buchman
  et al., 2017</xref>;
  <xref alt="Oinas et al., 2010" rid="ref-oinas_-synuclein_2010" ref-type="bibr">Oinas
  et al., 2010</xref>;
  <xref alt="Sumikura et al., 2015" rid="ref-sumikura_distribution_2015" ref-type="bibr">Sumikura
  et al., 2015</xref>). Their findings suggest that α-synuclein is
  relatively common in older adults without a diagnosis of PD, raising
  the possibility that its presence may serve as a preclinical marker of
  PD or related disorders, and contributing to a debate over whether
  such pathology reflects prodromal PD or incidental, non-pathogenic
  findings. Nonetheless, this may make it even more challenging to
  distinguish between HC and individuals with a clinical diagnosis of
  PD, since α-synuclein may also be present in older HC subjects in our
  cohort without clinical manifestation of the disease.</p>
  <p>In our work, we have observed an increase in ODI and decrease in FA
  in the cervical spinal cord in both HC and PD subjects. These results
  are consistent with work from other research groups that have explored
  the effect of age on these DWI metrics in healthy subjects
  (<xref alt="Agosta et al., 2007" rid="ref-agosta_evidence_2007" ref-type="bibr">Agosta
  et al., 2007</xref>).
  (<xref alt="Agosta et al., 2007" rid="ref-agosta_evidence_2007" ref-type="bibr">Agosta
  et al., 2007</xref>) have also reported no significant correlation
  between MD and age, which is also consistent with our findings. Other
  work with PD in the brain have also reported a negative correlation of
  FA with age in the substantia nigra
  (<xref alt="Oliveira &amp; Pereira, 2021" rid="ref-de_oliveira_utility_2021" ref-type="bibr">Oliveira
  &amp; Pereira, 2021</xref>).</p>
  <p>Our current study also revealed similar effects of age on our
  metrics as those observed with the UPDRSIII. In some regions and
  metrics, such as in the WM/GM in T2*w, our analysis revealed a
  stronger effect of age than the UPDRSIII on our metrics. This makes it
  difficult to differentiate between the effects of Parkinson’s disease
  progression and normal aging. Additionally, while age was included in
  the analysis, other potential confounding variables that could impact
  the progression of the disease, such as medication, should be
  considered in future work.</p>
  <p>Previous work have demonstrated relevance for the WM/GM in T2*w as
  a potential biomarker for spinal cord white matter injury, such as in
  the case of degenerative cervical myelopathy
  (<xref alt="Martin et al., 2017" rid="ref-martin_novel_2017" ref-type="bibr">Martin
  et al., 2017</xref>). To our knowledge, this study is the first to
  have explored its potential for PD in the spinal cord. However, our
  analysis did not reveal a significant correlation between the UPDRSIII
  and the WM/GM in T2*w. Further research will be necessary to establish
  definitive conclusions regarding its applicability in PD.</p>
  <p>Finally, in the current study, it was difficult to relate our
  findings for structural MRI in the spinal cord microstructure with
  those observed with functional MRI in
  (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
  et al., 2023</xref>) using the same subjects. In their work,
  (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
  et al., 2023</xref>) found a decrease in functional connectivity that
  correlated with upper limb motor symptoms in between PD patients
  between C4 and C6 spinal levels. However, our analysis did not reveal
  any significant microstructural findings that could be associated with
  the functional changes described in their work.</p>
  <p>Our analysis of spinal cord cross-sectional area (CSA) aligns with
  the findings of
  (<xref alt="Combes et al., 2024" rid="ref-combes_spiral_2024" ref-type="bibr">Combes
  et al., 2024</xref>), as we observed no structural changes due to PD.
  Indeed, our study revealed no significant differences in CSA between
  Parkinson’s disease (PD) subjects and healthy controls (HC).
  Additionally, no significant relationship between the UPDRSIII score
  and CSA was found. This absence of structural changes could explain
  the lack of significant correlations between PD and the examined
  MRI-derived metrics at the microstructural level. Furthermore, the
  evidence of no structural and microstructural changes within the gray
  matter may reinforce the findings of
  (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
  et al., 2023</xref>) observed through functional MRI, by suggesting
  that the effects of PD progression reported in their study were
  primarily driven by functional changes in the spinal cord rather than
  anatomical alterations. Nevertheless, subsequent work will be needed
  to confirm this.</p>
</sec>
<sec id="conclusion">
  <title>Conclusion</title>
  <p>In summary, this work is the first to have studied DTI, NODDI, MTR
  and T2*w metrics in the cervical spinal cord of a population with PD.
  Although some significant microstructural differences were identified
  between HC and PD subjects in isolated regions of the spinal
  cord—notably for FA and RD in the white matter — no significant
  changes in microstructural metrics were found in relation to the
  UPDRSIII score. Our results also suggest that age may have a greater
  effect on DTI, NODDI, MTR and T2*w metrics than the UPDRSIII in some
  regions of the cervical spinal cord. Our lack of significant findings
  in this current study suggest that the functional changes observed in
  the spinal cord of the same subjects in
  (<xref alt="Landelle et al., 2023" rid="ref-landelle_altered_2023" ref-type="bibr">Landelle
  et al., 2023</xref>) may be more sensitive markers that correlate with
  disease progression as assessed by clinical measures, such as
  UPDRSIII, than the structural measurements. This is consistent with
  findings from a mixed EEG-MRI study which reported reduced functional
  connectivity between superior and middle frontal gyrus and paracentral
  lobule in PD patients relative to healthy controls during an oddball
  auditory task, while no structural differences were observed in the
  DTI metrics between the same regions
  (<xref alt="Droby et al., 2022" rid="ref-droby_interplay_2022" ref-type="bibr">Droby
  et al., 2022</xref>).</p>
  <p>Nonetheless, this exploratory study provides insights into how the
  cervical spinal cord microstructure is only slightly affected by PD,
  and how it compares to normal aging processes in the spinal cord. The
  results are also in line with those of
  (<xref alt="Combes et al., 2024" rid="ref-combes_spiral_2024" ref-type="bibr">Combes
  et al., 2024</xref>), who did not find any structural changes between
  PD mice and non-transgenic mice.</p>
</sec>
<sec id="supplementary-material">
  <title>Supplementary material</title>
  <p>:::{figure} #suppl-fig1cell :label: suppl-fig1</p>
  <p>Correlations of DTI, NODDI, MTR and T2*w with the UPDRSIII score
  :::</p>
  <p>:::{figure} #suppl-fig2cell :label: suppl-fig2</p>
  <p>Correlations of DTI, NODDI, MTR and T2*w with age :::</p>
  <p>:::{figure} #suppl-fig3cell :label: suppl-fig3</p>
  <p>Correlations of CSA with (A) the UPDRSIII score and (B) with age
  :::</p>
</sec>
<sec id="acknowledgements">
  <title>Acknowledgements</title>
  <p>This work is supported by the TransMedTech Institute, thanks to the
  financial support of the Canada First Research Excellence Fund and the
  Fonds de recherche du Québec, the Fondation Courtois, the Natural
  Sciences and Engineering Research Council of Canada (NSERC), and
  Polytechnique Montreal. We thank the Clinical, Biospecimen, Imaging
  &amp; Genetic (C-BIG) repository for help in participant recruitment
  and the brain imaging centre of The Neuro for help in data
  acquisition. We thank all participants involved in this study.</p>
</sec>
</body>
<back>
<ref-list>
  <title></title>
  <ref id="ref-de_leener_pam50_2018">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>De Leener</surname><given-names>Benjamin</given-names></name>
        <name><surname>Fonov</surname><given-names>Vladimir S.</given-names></name>
        <name><surname>Collins</surname><given-names>D. Louis</given-names></name>
        <name><surname>Callot</surname><given-names>Virginie</given-names></name>
        <name><surname>Stikov</surname><given-names>Nikola</given-names></name>
        <name><surname>Cohen-Adad</surname><given-names>Julien</given-names></name>
      </person-group>
      <article-title>PAM50: Unbiased multimodal template of the brainstem and spinal cord aligned with the ICBM152 space</article-title>
      <source>NeuroImage</source>
      <year iso-8601-date="2018">2018</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-07-19">2024</year><month>07</month><day>19</day></date-in-citation>
      <volume>165</volume>
      <issn>1053-8119</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S1053811917308686</uri>
      <pub-id pub-id-type="doi">10.1016/j.neuroimage.2017.10.041</pub-id>
      <fpage>170</fpage>
      <lpage>179</lpage>
    </element-citation>
  </ref>
  <ref id="ref-kotian_diffusion_2020">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kotian</surname><given-names>Rahul P.</given-names></name>
        <name><surname>Prakashini</surname><given-names>K.</given-names></name>
        <name><surname>Nair</surname><given-names>N. Sreekumaran</given-names></name>
      </person-group>
      <article-title>A diffusion tensor imaging study to compare normative fractional anisotropy values with patients suffering from Parkinson’s disease in the brain grey and white matter</article-title>
      <source>Health and Technology</source>
      <year iso-8601-date="2020">2020</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-20">2023</year><month>10</month><day>20</day></date-in-citation>
      <volume>10</volume>
      <issue>5</issue>
      <issn>2190-7196</issn>
      <uri>https://doi.org/10.1007/s12553-020-00454-1</uri>
      <pub-id pub-id-type="doi">10.1007/s12553-020-00454-1</pub-id>
      <fpage>1283</fpage>
      <lpage>1289</lpage>
    </element-citation>
  </ref>
  <ref id="ref-atkinson-clement_diffusion_2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Atkinson-Clement</surname><given-names>Cyril</given-names></name>
        <name><surname>Pinto</surname><given-names>Serge</given-names></name>
        <name><surname>Eusebio</surname><given-names>Alexandre</given-names></name>
        <name><surname>Coulon</surname><given-names>Olivier</given-names></name>
      </person-group>
      <article-title>Diffusion tensor imaging in Parkinson’s disease: Review and meta-analysis</article-title>
      <source>NeuroImage: Clinical</source>
      <year iso-8601-date="2017">2017</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-20">2023</year><month>10</month><day>20</day></date-in-citation>
      <volume>16</volume>
      <issn>2213-1582</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S2213158217301766</uri>
      <pub-id pub-id-type="doi">10.1016/j.nicl.2017.07.011</pub-id>
      <fpage>98</fpage>
      <lpage>110</lpage>
    </element-citation>
  </ref>
  <ref id="ref-frostell_review_2016">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Frostell</surname><given-names>Arvid</given-names></name>
        <name><surname>Hakim</surname><given-names>Ramil</given-names></name>
        <name><surname>Thelin</surname><given-names>Eric Peter</given-names></name>
        <name><surname>Mattsson</surname><given-names>Per</given-names></name>
        <name><surname>Svensson</surname><given-names>Mikael</given-names></name>
      </person-group>
      <article-title>A Review of the Segmental Diameter of the Healthy Human Spinal Cord</article-title>
      <source>Frontiers in Neurology</source>
      <year iso-8601-date="2016-12">2016</year><month>12</month>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-04-23">2025</year><month>04</month><day>23</day></date-in-citation>
      <volume>7</volume>
      <issn>1664-2295</issn>
      <uri>https://www.frontiersin.orghttps://www.frontiersin.org/journals/neurology/articles/10.3389/fneur.2016.00238/full</uri>
      <pub-id pub-id-type="doi">10.3389/fneur.2016.00238</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-wang_age-related_2014">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Wang</surname><given-names>Kun</given-names></name>
        <name><surname>Song</surname><given-names>Qingxin</given-names></name>
        <name><surname>Zhang</surname><given-names>Fan</given-names></name>
        <name><surname>Chen</surname><given-names>Zhi</given-names></name>
        <name><surname>Hou</surname><given-names>Canglong</given-names></name>
        <name><surname>Tang</surname><given-names>Yixing</given-names></name>
        <name><surname>Chen</surname><given-names>Shiyue</given-names></name>
        <name><surname>Hao</surname><given-names>Qiang</given-names></name>
        <name><surname>Shen</surname><given-names>Hongxing</given-names></name>
      </person-group>
      <article-title>Age-related changes of the diffusion tensor imaging parameters of the normal cervical spinal cord</article-title>
      <source>European Journal of Radiology</source>
      <year iso-8601-date="2014-12">2014</year><month>12</month>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-04-23">2025</year><month>04</month><day>23</day></date-in-citation>
      <volume>83</volume>
      <issue>12</issue>
      <issn>0720-048X</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S0720048X14004380</uri>
      <pub-id pub-id-type="doi">10.1016/j.ejrad.2014.09.010</pub-id>
      <fpage>2196</fpage>
      <lpage>2202</lpage>
    </element-citation>
  </ref>
  <ref id="ref-de_oliveira_utility_2021">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Oliveira</surname><given-names>Romulo V de</given-names></name>
        <name><surname>Pereira</surname><given-names>João S</given-names></name>
      </person-group>
      <article-title>Utility of manual fractional anisotropy measurements in the management of patients with Parkinson disease: A feasibility study with a 1.5-T magnetic resonance imaging system</article-title>
      <source>Acta Radiologica Open</source>
      <year iso-8601-date="2021">2021</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-20">2023</year><month>10</month><day>20</day></date-in-citation>
      <volume>10</volume>
      <issue>2</issue>
      <issn>2058-4601</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7903830/</uri>
      <pub-id pub-id-type="doi">10.1177/2058460121993477</pub-id>
      <pub-id pub-id-type="pmid">33747550</pub-id>
      <fpage>2058460121993477</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-landelle_altered_2023">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Landelle</surname><given-names>Caroline</given-names></name>
        <name><surname>Dahlberg</surname><given-names>Linda Solstrand</given-names></name>
        <name><surname>Lungu</surname><given-names>Ovidiu</given-names></name>
        <name><surname>Misic</surname><given-names>Bratislav</given-names></name>
        <name><surname>De Leener</surname><given-names>Benjamin</given-names></name>
        <name><surname>Doyon</surname><given-names>Julien</given-names></name>
      </person-group>
      <article-title>Altered Spinal Cord Functional Connectivity Associated with Parkinson’s Disease Progression</article-title>
      <source>Movement Disorders</source>
      <year iso-8601-date="2023">2023</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-09-09">2023</year><month>09</month><day>09</day></date-in-citation>
      <volume>38</volume>
      <issue>4</issue>
      <issn>1531-8257</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1002/mds.29354</uri>
      <pub-id pub-id-type="doi">10.1002/mds.29354</pub-id>
      <fpage>636</fpage>
      <lpage>645</lpage>
    </element-citation>
  </ref>
  <ref id="ref-kamagata_what_2016">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kamagata</surname><given-names>Koji</given-names></name>
        <name><surname>Hatano</surname><given-names>Taku</given-names></name>
        <name><surname>Aoki</surname><given-names>Shigeki</given-names></name>
      </person-group>
      <article-title>What is NODDI and what is its role in Parkinson’s assessment?</article-title>
      <source>Expert Review of Neurotherapeutics</source>
      <year iso-8601-date="2016">2016</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-08-03">2023</year><month>08</month><day>03</day></date-in-citation>
      <volume>16</volume>
      <issue>3</issue>
      <issn>1473-7175</issn>
      <uri>https://doi.org/10.1586/14737175.2016.1142876</uri>
      <pub-id pub-id-type="doi">10.1586/14737175.2016.1142876</pub-id>
      <pub-id pub-id-type="pmid">26777076</pub-id>
      <fpage>241</fpage>
      <lpage>243</lpage>
    </element-citation>
  </ref>
  <ref id="ref-zhang_noddi_2012">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Zhang</surname><given-names>Hui</given-names></name>
        <name><surname>Schneider</surname><given-names>Torben</given-names></name>
        <name><surname>Wheeler-Kingshott</surname><given-names>Claudia A.</given-names></name>
        <name><surname>Alexander</surname><given-names>Daniel C.</given-names></name>
      </person-group>
      <article-title>NODDI: Practical in vivo neurite orientation dispersion and density imaging of the human brain</article-title>
      <source>NeuroImage</source>
      <year iso-8601-date="2012">2012</year>
      <volume>61</volume>
      <issue>4</issue>
      <issn>1095-9572</issn>
      <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.03.072</pub-id>
      <pub-id pub-id-type="pmid">22484410</pub-id>
      <fpage>1000</fpage>
      <lpage>1016</lpage>
    </element-citation>
  </ref>
  <ref id="ref-nyatega_gray_2022">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Nyatega</surname><given-names>Charles Okanda</given-names></name>
        <name><surname>Qiang</surname><given-names>Li</given-names></name>
        <name><surname>Adamu</surname><given-names>Mohammed Jajere</given-names></name>
        <name><surname>Kawuwa</surname><given-names>Halima Bello</given-names></name>
      </person-group>
      <article-title>Gray matter, white matter and cerebrospinal fluid abnormalities in Parkinson’s disease: A voxel-based morphometry study</article-title>
      <source>Frontiers in Psychiatry</source>
      <year iso-8601-date="2022">2022</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-07-31">2023</year><month>07</month><day>31</day></date-in-citation>
      <volume>13</volume>
      <issn>1664-0640</issn>
      <uri>https://www.frontiersin.org/articles/10.3389/fpsyt.2022.1027907</uri>
      <pub-id pub-id-type="doi">10.3389/fpsyt.2022.1027907</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-kamagata_neurite_2016">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Kamagata</surname><given-names>Koji</given-names></name>
        <name><surname>Hatano</surname><given-names>Taku</given-names></name>
        <name><surname>Okuzumi</surname><given-names>Ayami</given-names></name>
        <name><surname>Motoi</surname><given-names>Yumiko</given-names></name>
        <name><surname>Abe</surname><given-names>Osamu</given-names></name>
        <name><surname>Shimoji</surname><given-names>Keigo</given-names></name>
        <name><surname>Kamiya</surname><given-names>Kouhei</given-names></name>
        <name><surname>Suzuki</surname><given-names>Michimasa</given-names></name>
        <name><surname>Hori</surname><given-names>Masaaki</given-names></name>
        <name><surname>Kumamaru</surname><given-names>Kanako K.</given-names></name>
        <name><surname>Hattori</surname><given-names>Nobutaka</given-names></name>
        <name><surname>Aoki</surname><given-names>Shigeki</given-names></name>
      </person-group>
      <article-title>Neurite orientation dispersion and density imaging in the substantia nigra in idiopathic Parkinson disease</article-title>
      <source>European Radiology</source>
      <year iso-8601-date="2016">2016</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-07-27">2023</year><month>07</month><day>27</day></date-in-citation>
      <volume>26</volume>
      <issue>8</issue>
      <issn>1432-1084</issn>
      <uri>https://doi.org/10.1007/s00330-015-4066-8</uri>
      <pub-id pub-id-type="doi">10.1007/s00330-015-4066-8</pub-id>
      <fpage>2567</fpage>
      <lpage>2577</lpage>
    </element-citation>
  </ref>
  <ref id="ref-de_leener_sct_2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>De Leener</surname><given-names>Benjamin</given-names></name>
        <name><surname>Lévy</surname><given-names>Simon</given-names></name>
        <name><surname>Dupont</surname><given-names>Sara M.</given-names></name>
        <name><surname>Fonov</surname><given-names>Vladimir S.</given-names></name>
        <name><surname>Stikov</surname><given-names>Nikola</given-names></name>
        <name><surname>Louis Collins</surname><given-names>D.</given-names></name>
        <name><surname>Callot</surname><given-names>Virginie</given-names></name>
        <name><surname>Cohen-Adad</surname><given-names>Julien</given-names></name>
      </person-group>
      <article-title>SCT: Spinal Cord Toolbox, an open-source software for processing spinal cord MRI data</article-title>
      <source>NeuroImage</source>
      <year iso-8601-date="2017">2017</year>
      <volume>145</volume>
      <issue>Pt A</issue>
      <issn>1095-9572</issn>
      <pub-id pub-id-type="doi">10.1016/j.neuroimage.2016.10.009</pub-id>
      <pub-id pub-id-type="pmid">27720818</pub-id>
      <fpage>24</fpage>
      <lpage>43</lpage>
    </element-citation>
  </ref>
  <ref id="ref-muller_staging_2005">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Muller</surname><given-names>Christian M</given-names></name>
        <name><surname>Thal</surname><given-names>Dietmar R</given-names></name>
        <name><surname>Tolnay</surname><given-names>Markus</given-names></name>
        <name><surname>Braak</surname><given-names>Heiko</given-names></name>
      </person-group>
      <article-title>Staging of Sporadic Parkinson Disease-Related a-Synuclein Pathology: Inter- and Intra-Rater Reliability</article-title>
      <source>J Neuropathol Exp Neurol</source>
      <year iso-8601-date="2005">2005</year>
      <volume>64</volume>
      <issue>7</issue>
      <pub-id pub-id-type="doi">10.1097/01.jnen.0000171652.40083.15</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-martin_novel_2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Martin</surname><given-names>A. R.</given-names></name>
        <name><surname>De Leener</surname><given-names>B.</given-names></name>
        <name><surname>Cohen-Adad</surname><given-names>J.</given-names></name>
        <name><surname>Cadotte</surname><given-names>D. W.</given-names></name>
        <name><surname>Kalsi-Ryan</surname><given-names>S.</given-names></name>
        <name><surname>Lange</surname><given-names>S. F.</given-names></name>
        <name><surname>Tetreault</surname><given-names>L.</given-names></name>
        <name><surname>Nouri</surname><given-names>A.</given-names></name>
        <name><surname>Crawley</surname><given-names>A.</given-names></name>
        <name><surname>Mikulis</surname><given-names>D. J.</given-names></name>
        <name><surname>Ginsberg</surname><given-names>H.</given-names></name>
        <name><surname>Fehlings</surname><given-names>M. G.</given-names></name>
      </person-group>
      <article-title>A Novel MRI Biomarker of Spinal Cord White Matter Injury: T2*-Weighted White Matter to Gray Matter Signal Intensity Ratio</article-title>
      <source>American Journal of Neuroradiology</source>
      <year iso-8601-date="2017">2017</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-04-05">2024</year><month>04</month><day>05</day></date-in-citation>
      <volume>38</volume>
      <issue>6</issue>
      <issn>0195-6108</issn>
      <uri>http://www.ajnr.org/lookup/doi/10.3174/ajnr.A5162</uri>
      <pub-id pub-id-type="doi">10.3174/ajnr.A5162</pub-id>
      <fpage>1266</fpage>
      <lpage>1273</lpage>
    </element-citation>
  </ref>
  <ref id="ref-agosta_evidence_2007">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Agosta</surname><given-names>Federica</given-names></name>
        <name><surname>Laganà</surname><given-names>Marcella</given-names></name>
        <name><surname>Valsasina</surname><given-names>Paola</given-names></name>
        <name><surname>Sala</surname><given-names>Stefania</given-names></name>
        <name><surname>Dall’Occhio</surname><given-names>Luca</given-names></name>
        <name><surname>Sormani</surname><given-names>Maria P.</given-names></name>
        <name><surname>Judica</surname><given-names>Elda</given-names></name>
        <name><surname>Filippi</surname><given-names>Massimo</given-names></name>
      </person-group>
      <article-title>Evidence for cervical cord tissue disorganisation with aging by diffusion tensor MRI</article-title>
      <source>NeuroImage</source>
      <year iso-8601-date="2007">2007</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-03-01">2024</year><month>03</month><day>01</day></date-in-citation>
      <volume>36</volume>
      <issue>3</issue>
      <issn>1053-8119</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S1053811907002777</uri>
      <pub-id pub-id-type="doi">10.1016/j.neuroimage.2007.03.048</pub-id>
      <fpage>728</fpage>
      <lpage>735</lpage>
    </element-citation>
  </ref>
  <ref id="ref-sumikura_distribution_2015">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Sumikura</surname><given-names>Hiroyuki</given-names></name>
        <name><surname>Takao</surname><given-names>Masaki</given-names></name>
        <name><surname>Hatsuta</surname><given-names>Hiroyuki</given-names></name>
        <name><surname>Ito</surname><given-names>Shinji</given-names></name>
        <name><surname>Nakano</surname><given-names>Yuta</given-names></name>
        <name><surname>Uchino</surname><given-names>Akiko</given-names></name>
        <name><surname>Nogami</surname><given-names>Akane</given-names></name>
        <name><surname>Saito</surname><given-names>Yuko</given-names></name>
        <name><surname>Mochizuki</surname><given-names>Hideki</given-names></name>
        <name><surname>Murayama</surname><given-names>Shigeo</given-names></name>
      </person-group>
      <article-title>Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons</article-title>
      <source>Acta Neuropathologica Communications</source>
      <year iso-8601-date="2015">2015</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-02-29">2024</year><month>02</month><day>29</day></date-in-citation>
      <volume>3</volume>
      <issn>2051-5960</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4571135/</uri>
      <pub-id pub-id-type="doi">10.1186/s40478-015-0236-9</pub-id>
      <pub-id pub-id-type="pmid">26374630</pub-id>
      <fpage>57</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-oinas_-synuclein_2010">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Oinas</surname><given-names>Minna</given-names></name>
        <name><surname>Paetau</surname><given-names>Anders</given-names></name>
        <name><surname>Myllykangas</surname><given-names>Liisa</given-names></name>
        <name><surname>Notkola</surname><given-names>Irma-Leena</given-names></name>
        <name><surname>Kalimo</surname><given-names>Hannu</given-names></name>
        <name><surname>Polvikoski</surname><given-names>Tuomo</given-names></name>
      </person-group>
      <article-title>Α-Synuclein pathology in the spinal cord autonomic nuclei associates with α-synuclein pathology in the brain: A population-based Vantaa 85+ study</article-title>
      <source>Acta Neuropathologica</source>
      <year iso-8601-date="2010">2010</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-02-29">2024</year><month>02</month><day>29</day></date-in-citation>
      <volume>119</volume>
      <issue>6</issue>
      <issn>1432-0533</issn>
      <uri>https://doi.org/10.1007/s00401-009-0629-6</uri>
      <pub-id pub-id-type="doi">10.1007/s00401-009-0629-6</pub-id>
      <fpage>715</fpage>
      <lpage>722</lpage>
    </element-citation>
  </ref>
  <ref id="ref-bloch_-synuclein_2006">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Bloch</surname><given-names>A.</given-names></name>
        <name><surname>Probst</surname><given-names>A.</given-names></name>
        <name><surname>Bissig</surname><given-names>H.</given-names></name>
        <name><surname>Adams</surname><given-names>H.</given-names></name>
        <name><surname>Tolnay</surname><given-names>M.</given-names></name>
      </person-group>
      <article-title>Α-Synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects</article-title>
      <source>Neuropathology and Applied Neurobiology</source>
      <year iso-8601-date="2006">2006</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-02-29">2024</year><month>02</month><day>29</day></date-in-citation>
      <volume>32</volume>
      <issue>3</issue>
      <issn>1365-2990</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2990.2006.00727.x</uri>
      <pub-id pub-id-type="doi">10.1111/j.1365-2990.2006.00727.x</pub-id>
      <fpage>284</fpage>
      <lpage>295</lpage>
    </element-citation>
  </ref>
  <ref id="ref-odonnell_introduction_2011">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>O’Donnell</surname><given-names>Lauren J.</given-names></name>
        <name><surname>Westin</surname><given-names>Carl-Fredrik</given-names></name>
      </person-group>
      <article-title>An introduction to diffusion tensor image analysis</article-title>
      <source>Neurosurgery clinics of North America</source>
      <year iso-8601-date="2011">2011</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-11-06">2023</year><month>11</month><day>06</day></date-in-citation>
      <volume>22</volume>
      <issue>2</issue>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3163395/</uri>
      <pub-id pub-id-type="doi">10.1016/j.nec.2010.12.004</pub-id>
      <pub-id pub-id-type="pmid">21435570</pub-id>
      <fpage>185</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-schwarz_parkinsons_2018">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Schwarz</surname><given-names>Stefan Theodor</given-names></name>
        <name><surname>Mougin</surname><given-names>Olivier</given-names></name>
        <name><surname>Xing</surname><given-names>Yue</given-names></name>
        <name><surname>Blazejewska</surname><given-names>Anna</given-names></name>
        <name><surname>Bajaj</surname><given-names>Nin</given-names></name>
        <name><surname>Auer</surname><given-names>Dorothee P.</given-names></name>
        <name><surname>Gowland</surname><given-names>Penny</given-names></name>
      </person-group>
      <article-title>Parkinson’s disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI</article-title>
      <source>NeuroImage: Clinical</source>
      <year iso-8601-date="2018">2018</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>19</volume>
      <issn>2213-1582</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S2213158218301736</uri>
      <pub-id pub-id-type="doi">10.1016/j.nicl.2018.05.027</pub-id>
      <fpage>683</fpage>
      <lpage>689</lpage>
    </element-citation>
  </ref>
  <ref id="ref-tambasco_t2-weighted_2019">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Tambasco</surname><given-names>Nicola</given-names></name>
        <name><surname>Paolini Paoletti</surname><given-names>Federico</given-names></name>
        <name><surname>Chiappiniello</surname><given-names>Andrea</given-names></name>
        <name><surname>Lisetti</surname><given-names>Viviana</given-names></name>
        <name><surname>Nigro</surname><given-names>Pasquale</given-names></name>
        <name><surname>Eusebi</surname><given-names>Paolo</given-names></name>
        <name><surname>Chiarini</surname><given-names>Pietro</given-names></name>
        <name><surname>Romoli</surname><given-names>Michele</given-names></name>
        <name><surname>Brahimi</surname><given-names>Elona</given-names></name>
        <name><surname>Simoni</surname><given-names>Simone</given-names></name>
        <name><surname>Filidei</surname><given-names>Marta</given-names></name>
        <name><surname>Floridi</surname><given-names>Piero</given-names></name>
        <name><surname>Tarducci</surname><given-names>Roberto</given-names></name>
        <name><surname>Parnetti</surname><given-names>Lucilla</given-names></name>
        <name><surname>Calabresi</surname><given-names>Paolo</given-names></name>
      </person-group>
      <article-title>T2*-weighted MRI values correlate with motor and cognitive dysfunction in Parkinson’s disease</article-title>
      <source>Neurobiology of Aging</source>
      <year iso-8601-date="2019">2019</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>80</volume>
      <uri>https://linkinghub.elsevier.com/retrieve/pii/S0197458019301125</uri>
      <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2019.04.005</pub-id>
      <fpage>91</fpage>
      <lpage>98</lpage>
    </element-citation>
  </ref>
  <ref id="ref-anik_magnetization_2007">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Anik</surname><given-names>Yonca</given-names></name>
        <name><surname>Iseri</surname><given-names>Pervin</given-names></name>
        <name><surname>Demirci</surname><given-names>Ali</given-names></name>
        <name><surname>Komsuoglu</surname><given-names>Sezer</given-names></name>
        <name><surname>Inan</surname><given-names>Nagihan</given-names></name>
      </person-group>
      <article-title>Magnetization Transfer Ratio in Early Period of Parkinson Disease</article-title>
      <source>Academic Radiology</source>
      <year iso-8601-date="2007">2007</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>14</volume>
      <issue>2</issue>
      <issn>1076-6332</issn>
      <uri>https://www.sciencedirect.com/science/article/pii/S1076633206006714</uri>
      <pub-id pub-id-type="doi">10.1016/j.acra.2006.11.005</pub-id>
      <fpage>189</fpage>
      <lpage>192</lpage>
    </element-citation>
  </ref>
  <ref id="ref-tambasco_magnetization_2011">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Tambasco</surname><given-names>N.</given-names></name>
        <name><surname>Belcastro</surname><given-names>V.</given-names></name>
        <name><surname>Sarchielli</surname><given-names>P.</given-names></name>
        <name><surname>Floridi</surname><given-names>P.</given-names></name>
        <name><surname>Pierguidi</surname><given-names>L.</given-names></name>
        <name><surname>Menichetti</surname><given-names>C.</given-names></name>
        <name><surname>Castrioto</surname><given-names>A.</given-names></name>
        <name><surname>Chiarini</surname><given-names>P.</given-names></name>
        <name><surname>Parnetti</surname><given-names>L.</given-names></name>
        <name><surname>Eusebi</surname><given-names>P.</given-names></name>
        <name><surname>Calabresi</surname><given-names>P.</given-names></name>
        <name><surname>Rossi</surname><given-names>A.</given-names></name>
      </person-group>
      <article-title>A magnetization transfer study of mild and advanced Parkinson’s disease</article-title>
      <source>European Journal of Neurology</source>
      <year iso-8601-date="2011">2011</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>18</volume>
      <issue>3</issue>
      <issn>1468-1331</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1468-1331.2010.03184.x</uri>
      <pub-id pub-id-type="doi">10.1111/j.1468-1331.2010.03184.x</pub-id>
      <fpage>471</fpage>
      <lpage>477</lpage>
    </element-citation>
  </ref>
  <ref id="ref-sekigawa_role_2015">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Sekigawa</surname><given-names>Akio</given-names></name>
        <name><surname>Takamatsu</surname><given-names>Yoshiki</given-names></name>
        <name><surname>Sekiyama</surname><given-names>Kazunari</given-names></name>
        <name><surname>Hashimoto</surname><given-names>Makoto</given-names></name>
      </person-group>
      <article-title>Role of α- and β-Synucleins in the Axonal Pathology of Parkinson’s Disease and Related Synucleinopathies</article-title>
      <source>Biomolecules</source>
      <year iso-8601-date="2015">2015</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>5</volume>
      <issue>2</issue>
      <issn>2218-273X</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496706/</uri>
      <pub-id pub-id-type="doi">10.3390/biom5021000</pub-id>
      <pub-id pub-id-type="pmid">25996784</pub-id>
      <fpage>1000</fpage>
      <lpage>1011</lpage>
    </element-citation>
  </ref>
  <ref id="ref-nardone_spinal_2020">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Nardone</surname><given-names>Raffaele</given-names></name>
        <name><surname>Höller</surname><given-names>Yvonne</given-names></name>
        <name><surname>Brigo</surname><given-names>Francesco</given-names></name>
        <name><surname>Versace</surname><given-names>Viviana</given-names></name>
        <name><surname>Sebastianelli</surname><given-names>Luca</given-names></name>
        <name><surname>Florea</surname><given-names>Cristina</given-names></name>
        <name><surname>Schwenker</surname><given-names>Kerstin</given-names></name>
        <name><surname>Golaszewski</surname><given-names>Stefan</given-names></name>
        <name><surname>Saltuari</surname><given-names>Leopold</given-names></name>
        <name><surname>Trinka</surname><given-names>Eugen</given-names></name>
      </person-group>
      <article-title>Spinal cord involvement in Lewy body-related α-synucleinopathies</article-title>
      <source>The Journal of Spinal Cord Medicine</source>
      <year iso-8601-date="2020">2020</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>43</volume>
      <issue>6</issue>
      <issn>1079-0268</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7808259/</uri>
      <pub-id pub-id-type="doi">10.1080/10790268.2018.1557863</pub-id>
      <pub-id pub-id-type="pmid">30620687</pub-id>
      <fpage>832</fpage>
      <lpage>845</lpage>
    </element-citation>
  </ref>
  <ref id="ref-braak_parkinsons_2007">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Braak</surname><given-names>Heiko</given-names></name>
        <name><surname>Sastre</surname><given-names>Magdalena</given-names></name>
        <name><surname>Bohl</surname><given-names>Jürgen R. E.</given-names></name>
        <name><surname>Vos</surname><given-names>Rob A. I. de</given-names></name>
        <name><surname>Del Tredici</surname><given-names>Kelly</given-names></name>
      </person-group>
      <article-title>Parkinson’s disease: Lesions in dorsal horn layer I, involvement of parasympathetic and sympathetic pre- and postganglionic neurons</article-title>
      <source>Acta Neuropathologica</source>
      <year iso-8601-date="2007">2007</year>
      <volume>113</volume>
      <issue>4</issue>
      <issn>0001-6322</issn>
      <pub-id pub-id-type="doi">10.1007/s00401-007-0193-x</pub-id>
      <pub-id pub-id-type="pmid">17294202</pub-id>
      <fpage>421</fpage>
      <lpage>429</lpage>
    </element-citation>
  </ref>
  <ref id="ref-buchman_spinal_2017">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Buchman</surname><given-names>Aron S.</given-names></name>
        <name><surname>Nag</surname><given-names>Sukriti</given-names></name>
        <name><surname>Leurgans</surname><given-names>Sue E.</given-names></name>
        <name><surname>Miller</surname><given-names>Jared</given-names></name>
        <name><surname>VanderHorst</surname><given-names>Veronique G. J. M.</given-names></name>
        <name><surname>Bennett</surname><given-names>David A.</given-names></name>
        <name><surname>Schneider</surname><given-names>Julie A.</given-names></name>
      </person-group>
      <article-title>Spinal Lewy body pathology in older adults without an antemortem diagnosis of Parkinson’s disease</article-title>
      <source>Brain Pathology</source>
      <year iso-8601-date="2017">2017</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <volume>28</volume>
      <issue>4</issue>
      <issn>1015-6305</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874164/</uri>
      <pub-id pub-id-type="doi">10.1111/bpa.12560</pub-id>
      <pub-id pub-id-type="pmid">28960595</pub-id>
      <fpage>560</fpage>
      <lpage>568</lpage>
    </element-citation>
  </ref>
  <ref id="ref-bianco_-synucleinopathy_2002">
    <element-citation>
      <person-group person-group-type="author">
        <name><surname>Bianco</surname><given-names>C. Lo</given-names></name>
        <name><surname>Ridet</surname><given-names>J. L.</given-names></name>
        <name><surname>Schneider</surname><given-names>B. L.</given-names></name>
        <name><surname>Déglon</surname><given-names>N.</given-names></name>
        <name><surname>Aebischer</surname><given-names>P.</given-names></name>
      </person-group>
      <article-title>Α-Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson’s disease</article-title>
      <year iso-8601-date="2002">2002</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-25">2023</year><month>10</month><day>25</day></date-in-citation>
      <uri>https://www.pnas.org/doi/10.1073/pnas.152339799</uri>
      <pub-id pub-id-type="doi">10.1073/pnas.152339799</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-mitchell_neurite_2019">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Mitchell</surname><given-names>Trina</given-names></name>
        <name><surname>Archer</surname><given-names>Derek B.</given-names></name>
        <name><surname>Chu</surname><given-names>Winston T.</given-names></name>
        <name><surname>Coombes</surname><given-names>Stephen A.</given-names></name>
        <name><surname>Lai</surname><given-names>Song</given-names></name>
        <name><surname>Wilkes</surname><given-names>Bradley J.</given-names></name>
        <name><surname>McFarland</surname><given-names>Nikolaus R.</given-names></name>
        <name><surname>Okun</surname><given-names>Michael S.</given-names></name>
        <name><surname>Black</surname><given-names>Mieniecia L.</given-names></name>
        <name><surname>Herschel</surname><given-names>Ellen</given-names></name>
        <name><surname>Simuni</surname><given-names>Tanya</given-names></name>
        <name><surname>Comella</surname><given-names>Cynthia</given-names></name>
        <name><surname>Xie</surname><given-names>Tao</given-names></name>
        <name><surname>Li</surname><given-names>Hong</given-names></name>
        <name><surname>Parrish</surname><given-names>Todd B.</given-names></name>
        <name><surname>Kurani</surname><given-names>Ajay S.</given-names></name>
        <name><surname>Corcos</surname><given-names>Daniel M.</given-names></name>
        <name><surname>Vaillancourt</surname><given-names>David E.</given-names></name>
      </person-group>
      <article-title>Neurite orientation dispersion and density imaging (NODDI) and free-water imaging in Parkinsonism</article-title>
      <source>Human Brain Mapping</source>
      <year iso-8601-date="2019">2019</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-24">2023</year><month>10</month><day>24</day></date-in-citation>
      <volume>40</volume>
      <issue>17</issue>
      <issn>1097-0193</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1002/hbm.24760</uri>
      <pub-id pub-id-type="doi">10.1002/hbm.24760</pub-id>
      <fpage>5094</fpage>
      <lpage>5107</lpage>
    </element-citation>
  </ref>
  <ref id="ref-del_tredici_spinal_2012">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Del Tredici</surname><given-names>Kelly</given-names></name>
        <name><surname>Braak</surname><given-names>Heiko</given-names></name>
      </person-group>
      <article-title>Spinal cord lesions in sporadic Parkinson’s disease</article-title>
      <source>Acta Neuropathologica</source>
      <year iso-8601-date="2012">2012</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2023-10-23">2023</year><month>10</month><day>23</day></date-in-citation>
      <volume>124</volume>
      <issue>5</issue>
      <issn>1432-0533</issn>
      <uri>https://doi.org/10.1007/s00401-012-1028-y</uri>
      <pub-id pub-id-type="doi">10.1007/s00401-012-1028-y</pub-id>
      <fpage>643</fpage>
      <lpage>664</lpage>
    </element-citation>
  </ref>
  <ref id="ref-combes_spiral_2024">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Combes</surname><given-names>Benjamin F.</given-names></name>
        <name><surname>Kalva</surname><given-names>Sandeep Kumar</given-names></name>
        <name><surname>Benveniste</surname><given-names>Pierre-Louis</given-names></name>
        <name><surname>Tournant</surname><given-names>Agathe</given-names></name>
        <name><surname>Law</surname><given-names>Man Hoi</given-names></name>
        <name><surname>Newton</surname><given-names>Joshua</given-names></name>
        <name><surname>Krüger</surname><given-names>Maik</given-names></name>
        <name><surname>Weber</surname><given-names>Rebecca Z.</given-names></name>
        <name><surname>Dias</surname><given-names>Inês</given-names></name>
        <name><surname>Noain</surname><given-names>Daniela</given-names></name>
        <name><surname>Dean-Ben</surname><given-names>Xose Luis</given-names></name>
        <name><surname>Konietzko</surname><given-names>Uwe</given-names></name>
        <name><surname>Baumann</surname><given-names>Christian R.</given-names></name>
        <name><surname>Gillberg</surname><given-names>Per-Göran</given-names></name>
        <name><surname>Hock</surname><given-names>Christoph</given-names></name>
        <name><surname>Nitsch</surname><given-names>Roger M.</given-names></name>
        <name><surname>Cohen-Adad</surname><given-names>Julien</given-names></name>
        <name><surname>Razansky</surname><given-names>Daniel</given-names></name>
        <name><surname>Ni</surname><given-names>Ruiqing</given-names></name>
      </person-group>
      <article-title>Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson’s disease</article-title>
      <source>European Journal of Nuclear Medicine and Molecular Imaging</source>
      <year iso-8601-date="2024">2024</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2024-10-20">2024</year><month>10</month><day>20</day></date-in-citation>
      <issn>1619-7089</issn>
      <uri>https://doi.org/10.1007/s00259-024-06938-w</uri>
      <pub-id pub-id-type="doi">10.1007/s00259-024-06938-w</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-ucl_microstructure_imaging_group_noddi_2021">
    <element-citation>
      <person-group person-group-type="author">
        <string-name>UCL Microstructure Imaging Group</string-name>
      </person-group>
      <article-title>NODDI Matlab Toolbox</article-title>
      <publisher-loc>University Collece London</publisher-loc>
      <year iso-8601-date="2021">2021</year>
      <uri>http://mig.cs.ucl.ac.uk/index.php?n=Tutorial.NODDImatlab</uri>
    </element-citation>
  </ref>
  <ref id="ref-del_tredici_review_2016">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Del Tredici</surname><given-names>K.</given-names></name>
        <name><surname>Braak</surname><given-names>H.</given-names></name>
      </person-group>
      <article-title>Review: Sporadic Parkinson’s disease: Development and distribution of α-synuclein pathology</article-title>
      <source>Neuropathology and Applied Neurobiology</source>
      <year iso-8601-date="2016">2016</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-01-14">2025</year><month>01</month><day>14</day></date-in-citation>
      <volume>42</volume>
      <issue>1</issue>
      <issn>1365-2990</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1111/nan.12298</uri>
      <pub-id pub-id-type="doi">10.1111/nan.12298</pub-id>
      <fpage>33</fpage>
      <lpage>50</lpage>
    </element-citation>
  </ref>
  <ref id="ref-assaf_diffusion_2008">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Assaf</surname><given-names>Yaniv</given-names></name>
        <name><surname>Pasternak</surname><given-names>Ofer</given-names></name>
      </person-group>
      <article-title>Diffusion Tensor Imaging (DTI)-based White Matter Mapping in Brain Research: A Review</article-title>
      <source>Journal of Molecular Neuroscience</source>
      <year iso-8601-date="2008">2008</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-01-20">2025</year><month>01</month><day>20</day></date-in-citation>
      <volume>34</volume>
      <issue>1</issue>
      <issn>1559-1166</issn>
      <uri>https://doi.org/10.1007/s12031-007-0029-0</uri>
      <pub-id pub-id-type="doi">10.1007/s12031-007-0029-0</pub-id>
      <fpage>51</fpage>
      <lpage>61</lpage>
    </element-citation>
  </ref>
  <ref id="ref-pfefferbaum_diffusion_2010">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Pfefferbaum</surname><given-names>Adolf</given-names></name>
        <name><surname>Adalsteinsson</surname><given-names>Elfar</given-names></name>
        <name><surname>Rohlfing</surname><given-names>Torsten</given-names></name>
        <name><surname>Sullivan</surname><given-names>Edith V.</given-names></name>
      </person-group>
      <article-title>Diffusion tensor imaging of deep gray matter brain structures: Effects of age and iron concentration</article-title>
      <source>Neurobiology of aging</source>
      <year iso-8601-date="2010">2010</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-01-20">2025</year><month>01</month><day>20</day></date-in-citation>
      <volume>31</volume>
      <issue>3</issue>
      <issn>0197-4580</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2815127/</uri>
      <pub-id pub-id-type="doi">10.1016/j.neurobiolaging.2008.04.013</pub-id>
      <pub-id pub-id-type="pmid">18513834</pub-id>
      <fpage>482</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-vedantam_diffusion_2014">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Vedantam</surname><given-names>Aditya</given-names></name>
        <name><surname>Jirjis</surname><given-names>Michael B.</given-names></name>
        <name><surname>Schmit</surname><given-names>Brian D.</given-names></name>
        <name><surname>Wang</surname><given-names>Marjorie C.</given-names></name>
        <name><surname>Ulmer</surname><given-names>John L.</given-names></name>
        <name><surname>Kurpad</surname><given-names>Shekar N.</given-names></name>
      </person-group>
      <article-title>Diffusion Tensor Imaging of the Spinal Cord: Insights From Animal and Human Studies</article-title>
      <source>Neurosurgery</source>
      <year iso-8601-date="2014-01">2014</year><month>01</month>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-04-23">2025</year><month>04</month><day>23</day></date-in-citation>
      <volume>74</volume>
      <issue>1</issue>
      <issn>0148-396X</issn>
      <uri>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986512/</uri>
      <pub-id pub-id-type="doi">10.1227/NEU.0000000000000171</pub-id>
      <pub-id pub-id-type="pmid">24064483</pub-id>
      <fpage>1</fpage>
      <lpage>8</lpage>
    </element-citation>
  </ref>
  <ref id="ref-zeng_iron_2024">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Zeng</surname><given-names>Weiqi</given-names></name>
        <name><surname>Cai</surname><given-names>Jin</given-names></name>
        <name><surname>Zhang</surname><given-names>Lei</given-names></name>
        <name><surname>Peng</surname><given-names>Qiwei</given-names></name>
      </person-group>
      <article-title>Iron Deposition in Parkinson’s Disease: A Mini-Review</article-title>
      <source>Cellular and Molecular Neurobiology</source>
      <year iso-8601-date="2024">2024</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-02-18">2025</year><month>02</month><day>18</day></date-in-citation>
      <volume>44</volume>
      <issue>1</issue>
      <issn>1573-6830</issn>
      <uri>https://doi.org/10.1007/s10571-024-01459-4</uri>
      <pub-id pub-id-type="doi">10.1007/s10571-024-01459-4</pub-id>
      <fpage>26</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-horsager_brain-first_2020">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Horsager</surname><given-names>Jacob</given-names></name>
        <name><surname>Andersen</surname><given-names>Katrine B</given-names></name>
        <name><surname>Knudsen</surname><given-names>Karoline</given-names></name>
        <name><surname>Skjærbæk</surname><given-names>Casper</given-names></name>
        <name><surname>Fedorova</surname><given-names>Tatyana D</given-names></name>
        <name><surname>Okkels</surname><given-names>Niels</given-names></name>
        <name><surname>Schaeffer</surname><given-names>Eva</given-names></name>
        <name><surname>Bonkat</surname><given-names>Sarah K</given-names></name>
        <name><surname>Geday</surname><given-names>Jacob</given-names></name>
        <name><surname>Otto</surname><given-names>Marit</given-names></name>
        <name><surname>Sommerauer</surname><given-names>Michael</given-names></name>
        <name><surname>Danielsen</surname><given-names>Erik H</given-names></name>
        <name><surname>Bech</surname><given-names>Einar</given-names></name>
        <name><surname>Kraft</surname><given-names>Jonas</given-names></name>
        <name><surname>Munk</surname><given-names>Ole L</given-names></name>
        <name><surname>Hansen</surname><given-names>Sandra D</given-names></name>
        <name><surname>Pavese</surname><given-names>Nicola</given-names></name>
        <name><surname>Göder</surname><given-names>Robert</given-names></name>
        <name><surname>Brooks</surname><given-names>David J</given-names></name>
        <name><surname>Berg</surname><given-names>Daniela</given-names></name>
        <name><surname>Borghammer</surname><given-names>Per</given-names></name>
      </person-group>
      <article-title>Brain-first versus body-first Parkinson’s disease: A multimodal imaging case-control study</article-title>
      <source>Brain</source>
      <year iso-8601-date="2020">2020</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-02-19">2025</year><month>02</month><day>19</day></date-in-citation>
      <volume>143</volume>
      <issue>10</issue>
      <issn>0006-8950</issn>
      <uri>https://academic.oup.com/brain/article/143/10/3077/5896254</uri>
      <pub-id pub-id-type="doi">10.1093/brain/awaa238</pub-id>
      <fpage>3077</fpage>
      <lpage>3088</lpage>
    </element-citation>
  </ref>
  <ref id="ref-leclair-visonneau_gut_2020">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Leclair-Visonneau</surname><given-names>Laurène</given-names></name>
        <name><surname>Neunlist</surname><given-names>Michel</given-names></name>
        <name><surname>Derkinderen</surname><given-names>Pascal</given-names></name>
        <name><surname>Lebouvier</surname><given-names>Thibaud</given-names></name>
      </person-group>
      <article-title>The gut in Parkinson’s disease: Bottom-up, top-down, or neither?</article-title>
      <source>Neurogastroenterology &amp; Motility</source>
      <year iso-8601-date="2020">2020</year>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-02-19">2025</year><month>02</month><day>19</day></date-in-citation>
      <volume>32</volume>
      <issue>1</issue>
      <issn>1365-2982</issn>
      <uri>https://onlinelibrary.wiley.com/doi/abs/10.1111/nmo.13777</uri>
      <pub-id pub-id-type="doi">10.1111/nmo.13777</pub-id>
      <fpage>e13777</fpage>
      <lpage></lpage>
    </element-citation>
  </ref>
  <ref id="ref-droby_interplay_2022">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <name><surname>Droby</surname><given-names>Amgad</given-names></name>
        <name><surname>Nosatzki</surname><given-names>Shai</given-names></name>
        <name><surname>Edry</surname><given-names>Yariv</given-names></name>
        <name><surname>Thaler</surname><given-names>Avner</given-names></name>
        <name><surname>Giladi</surname><given-names>Nir</given-names></name>
        <name><surname>Mirelman</surname><given-names>Anat</given-names></name>
        <name><surname>Maidan</surname><given-names>Inbal</given-names></name>
      </person-group>
      <article-title>The interplay between structural and functional connectivity in early stage Parkinson’s disease patients</article-title>
      <source>Journal of the Neurological Sciences</source>
      <year iso-8601-date="2022-11">2022</year><month>11</month>
      <date-in-citation content-type="access-date"><year iso-8601-date="2025-04-16">2025</year><month>04</month><day>16</day></date-in-citation>
      <volume>442</volume>
      <issn>0022-510X</issn>
      <uri>https://www.jns-journal.com/article/S0022-510X(22)00314-8/abstract</uri>
      <pub-id pub-id-type="doi">10.1016/j.jns.2022.120452</pub-id>
      <pub-id pub-id-type="pmid">36265263</pub-id>
    </element-citation>
  </ref>
  <ref id="ref-movement_disorder_society_task_force_on_rating_scales_for_parkinsons_disease_unified_2003">
    <element-citation publication-type="article-journal">
      <person-group person-group-type="author">
        <string-name>Movement Disorder Society Task Force on Rating Scales for Parkinson’s Disease</string-name>
      </person-group>
      <article-title>The Unified Parkinson’s Disease Rating Scale (UPDRS): Status and recommendations</article-title>
      <source>Movement Disorders: Official Journal of the Movement Disorder Society</source>
      <year iso-8601-date="2003-07">2003</year><month>07</month>
      <volume>18</volume>
      <issue>7</issue>
      <issn>0885-3185</issn>
      <pub-id pub-id-type="doi">10.1002/mds.10473</pub-id>
      <pub-id pub-id-type="pmid">12815652</pub-id>
      <fpage>738</fpage>
      <lpage>750</lpage>
    </element-citation>
  </ref>
</ref-list>
</back>
</article>
